These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 26984528

  • 1. Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones.
    Malik M, Mustaev A, Schwanz HA, Luan G, Shah N, Oppegard LM, de Souza EC, Hiasa H, Zhao X, Kerns RJ, Drlica K.
    Nucleic Acids Res; 2016 Apr 20; 44(7):3304-16. PubMed ID: 26984528
    [Abstract] [Full Text] [Related]

  • 2. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
    Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM, Drlica K.
    J Biol Chem; 2014 May 02; 289(18):12300-12. PubMed ID: 24497635
    [Abstract] [Full Text] [Related]

  • 3. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
    Changkwanyeun R, Yamaguchi T, Kongsoi S, Changkaew K, Yokoyama K, Kim H, Suthienkul O, Usui M, Tamura Y, Nakajima C, Suzuki Y.
    Drug Test Anal; 2016 Oct 02; 8(10):1071-1076. PubMed ID: 26857529
    [Abstract] [Full Text] [Related]

  • 4. Bypassing fluoroquinolone resistance with quinazolinediones: studies of drug-gyrase-DNA complexes having implications for drug design.
    Drlica K, Mustaev A, Towle TR, Luan G, Kerns RJ, Berger JM.
    ACS Chem Biol; 2014 Dec 19; 9(12):2895-904. PubMed ID: 25310082
    [Abstract] [Full Text] [Related]

  • 5. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
    Zhou Y, Yu L, Li J, Zhang L, Tong Y, Kan B.
    Int J Antimicrob Agents; 2013 Jul 19; 42(1):72-5. PubMed ID: 23643392
    [Abstract] [Full Text] [Related]

  • 6. Molecular Dynamics Simulations of Quinolone Resistance-Associated T86I and P104S Mutations in Campylobacter jejuni gyrA: Unraveling Structural Repercussions.
    Mehla K, Ramana J.
    Microb Drug Resist; 2018 Apr 19; 24(3):232-243. PubMed ID: 28759328
    [Abstract] [Full Text] [Related]

  • 7. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
    Urushibara N, Suzaki K, Kawaguchiya M, Aung MS, Shinagawa M, Takahashi S, Kobayashi N.
    Microb Drug Resist; 2018 Apr 19; 24(1):1-7. PubMed ID: 28504916
    [Abstract] [Full Text] [Related]

  • 8. Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.
    Aldred KJ, Blower TR, Kerns RJ, Berger JM, Osheroff N.
    Proc Natl Acad Sci U S A; 2016 Feb 16; 113(7):E839-46. PubMed ID: 26792518
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
    Strahilevitz J, Robicsek A, Hooper DC.
    Antimicrob Agents Chemother; 2006 Feb 16; 50(2):600-6. PubMed ID: 16436716
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N, Davies TA, Goldschmidt R.
    Antimicrob Agents Chemother; 2005 Jun 16; 49(6):2479-86. PubMed ID: 15917550
    [Abstract] [Full Text] [Related]

  • 13. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC.
    Int J Antimicrob Agents; 2010 Jan 16; 35(1):76-9. PubMed ID: 19781915
    [Abstract] [Full Text] [Related]

  • 14. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX, Hu YJ, Zhou HW, Zhang R, Chen GX.
    Microb Drug Resist; 2015 Jun 16; 21(3):345-51. PubMed ID: 25514581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis.
    Mehla K, Ramana J.
    OMICS; 2016 Nov 16; 20(11):635-644. PubMed ID: 27753544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.